Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 585,788 | 786,804 | 764,104 | 622,385 | 1,010,701 |
| Marketable Securities | 821,888 | 836,270 | 637,219 | 779,023 | 554,227 |
| Receivables | 550,995 | 511,286 | 481,214 | 446,665 | 484,636 |
| Inventories | 278,686 | 268,529 | 268,076 | 263,602 | 249,858 |
| Other current assets | 334,902 | 341,389 | 330,040 | 346,325 | 339,658 |
| TOTAL | $2,572,259 | $2,744,278 | $2,480,653 | $2,458,000 | $2,639,080 |
| Non-Current Assets | |||||
| PPE Net | 1,634,696 | 1,608,660 | 1,562,174 | 1,594,754 | 1,579,938 |
| Investments And Advances | 1,753,746 | 1,307,118 | 1,321,949 | 1,126,558 | 927,877 |
| Intangibles | 3,065,736 | 3,117,140 | 3,210,430 | 3,299,679 | 3,388,313 |
| TOTAL | $6,454,178 | $6,032,918 | $6,094,553 | $6,020,991 | $5,896,128 |
| Total Assets | $9,026,437 | $8,777,196 | $8,575,206 | $8,478,991 | $8,535,208 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 108,547 | 210,941 | 104,271 | 137,408 | 301,641 |
| Accrued Expenses | 537,408 | 496,694 | 429,689 | 534,887 | 497,263 |
| TOTAL | $721,368 | $803,926 | $807,767 | $923,222 | $985,872 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,085,844 | 1,085,607 | 1,082,909 | 1,085,431 | 1,042,427 |
| aiOther Non-Current Liabilities | 329,822 | 328,956 | 315,900 | 278,596 | 297,255 |
| TOTAL | $1,707,259 | $1,727,565 | $1,747,185 | $1,721,817 | $1,780,858 |
| Total Liabilities | $2,428,627 | $2,531,491 | $2,554,952 | $2,645,039 | $2,766,730 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 289,199 | 288,856 | 288,559 | 297,253 | 291,753 |
| Common Shares | 149 | 149 | 149 | 149 | 149 |
| Retained earnings | 781,321 | 516,632 | 388,019 | 270,180 | 75,361 |
| Other shareholders' equity | 71,025 | 43,988 | 169 | 16,666 | 33,857 |
| TOTAL | $6,597,810 | $6,245,705 | $6,020,254 | $5,833,952 | $5,768,478 |
| Total Liabilities And Equity | $9,026,437 | $8,777,196 | $8,575,206 | $8,478,991 | $8,535,208 |